Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.12 USD | +1.73% | -0.24% | -44.77% |
22/05 | HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating | MT |
14/05 | Acelyrin, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 726.2 | 408 | - | - |
Enterprise Value (EV) 1 | 726.2 | 532.2 | 337.2 | 408 |
P/E ratio | -1.37 x | -1.35 x | -1.02 x | -1.29 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | - | - | 9.75 x |
EV / Revenue | - | - | - | 9.75 x |
EV / EBITDA | - | -1.28 x | -0.77 x | - |
EV / FCF | - | -1.72 x | -0.84 x | -0.87 x |
FCF Yield | - | -58% | -119% | -115% |
Price to Book | - | -1.74 x | -14.2 x | - |
Nbr of stocks (in thousands) | 97,339 | 99,027 | - | - |
Reference price 2 | 7.460 | 4.120 | 4.120 | 4.120 |
Announcement Date | 28/03/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | - | - | - | 41.86 |
EBITDA 1 | - | - | -416.4 | -437.4 | - |
EBIT 1 | - | -422.1 | -368.4 | -441.8 | -506.9 |
Operating Margin | - | - | - | - | -1,210.93% |
Earnings before Tax (EBT) 1 | - | -381.6 | -310.3 | -413.1 | -479.2 |
Net income 1 | -64.77 | -381.6 | -310.3 | -413.1 | -479.2 |
Net margin | - | - | - | - | -1,144.66% |
EPS 2 | -21.09 | -5.430 | -3.054 | -4.048 | -3.200 |
Free Cash Flow 1 | - | - | -308.5 | -401.5 | -470 |
FCF margin | - | - | - | - | -1,122.77% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 13/04/23 | 28/03/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - |
EBITDA 1 | - | - | - | - | -82.72 | -102.9 | -104.9 | - | - | - |
EBIT 1 | - | -42.7 | -94.42 | -105.1 | -82.77 | -84.63 | -91.93 | -101.4 | -115.9 | -117.5 |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -26.04 | -83.94 | -95.21 | -34.97 | -68.06 | -79.22 | -96.14 | -115.9 | -117.5 |
Net income 1 | -176.4 | -26.04 | -83.94 | -95.21 | -34.97 | -68.06 | -79.22 | -96.14 | -115.9 | -117.5 |
Net margin | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -8.610 | -0.4000 | -0.8700 | -0.7500 | -0.3600 | -0.6867 | -0.7967 | -0.9300 | -1.160 | -1.170 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 15/06/23 | 14/08/23 | 07/11/23 | 28/03/24 | 14/05/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | - | - | 124 | - | - |
Net Cash position 1 | - | - | - | 70.8 | - |
Leverage (Debt/EBITDA) | - | - | -0.2982 x | - | - |
Free Cash Flow 1 | - | - | -309 | -402 | -470 |
ROE (net income / shareholders' equity) | - | - | -80.9% | -207% | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share 2 | - | - | -2.370 | -0.2900 | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | - | 2.5 | 2.33 | 3 |
Capex / Sales | - | - | - | - | 7.17% |
Announcement Date | 13/04/23 | 28/03/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.77% | 408M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- SLRN Stock
- Financials Acelyrin, Inc.